{
    "nctId": "NCT05325151",
    "briefTitle": "Genetic Counseling Patient Preference Intervention Versus Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer",
    "officialTitle": "A Randomized Controlled Trial Comparing a Genetic Counseling Patient Preference Intervention vs. Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Carcinoma",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 1000,
    "primaryOutcomeMeasure": "Adherence to National Comprehensive Cancer Network (NCCN) guidelines of having a clinical encounter every 6-12 months",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Being female.\n* Ages 30-64.\n* Being an Ohio State University (OSU) patient who uses MyChart.\n* Undergoing routine screening mammography.\n* Normal BI-RADS1.\n* At elevated breast cancer risk by the Cancer Risk Assessment (CRA) tool.\n* Able to read and speak English.\n* Provide consent.\n\nExclusion Criteria:\n\n* Previous genetic counseling.\n* Previous genetic testing for cancer risk or known mutation in a breast cancer gene: ATM, BARD1, BRCA1, BRCA2, CDH1, CHEK2, NBN, PALB2, PTEN, TP53.\n* Previous diagnosis of breast or ovarian cancer or personal history of lobular carcinoma in situ (LCIS) or breast hyperplasia (with or without atypia).\n* Being a member of a focus group that assisted with the development of the intervention.",
    "sex": "FEMALE",
    "minimumAge": "30 Years",
    "stdAges": "ADULT"
}